Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Tapering of Mycophenolate Mofetil After High-Risk Allogeneic HSCT
jRCTs051180097Completed
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mycophenolate mofetil in Acute Leukaemia and myelodysplastic syndrome (MDS). Primary endpoint: Overall survival rate at 1 year after HSCT. Started Aug 2015; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Acute Leukaemiamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on jRCTs051180097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180097.